CIK 0001635088
- Large accelerated filer
Roivant Sciences Ltd.
Sign in to watch- Ticker
- ROIV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- Bermuda
- Entity type
- Operating
- EIN
- 981173944
- Phone
- +44 12955950
- Business address
- 7TH FLOOR, 50 BROADWAY, LONDON, United Kingdom, SW1H 0DB
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $70,369,463
- in 12 filings, $45.5M under 10b5-1 plans
Net −$70,369,463. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-27 | Sukhatme Mayukh Pres&Chief Investment Officer | Option exercise · Capped Value Appreciation Rights | −159,100 | $6.40 | $1.0M | 1,856,163 |
| 2023-12-27 | Sukhatme Mayukh Pres&Chief Investment Officer | Option exercise · Capped Value Appreciation Rights | −28,411 | $11.50 | $327K | 1,306,889 |
| 2023-12-27 | Kumar Rakhi Chief Accounting Officer | Option exercise 10b5-1 | +13 | 192,295 | ||
| 2023-12-27 | Kumar Rakhi Chief Accounting Officer | Shares withheld for taxes 10b5-1 | −6 | $11.58 | $69 | 192,289 |
| 2023-12-27 | Kumar Rakhi Chief Accounting Officer | Option exercise · Capped Value Appreciation Rights 10b5-1 | −1,894 | $11.50 | $22K | 87,126 |
| 2023-12-20 | Venker Eric President & COO | Shares withheld for taxes 10b5-1 | −16,003 | $9.96 | $159K | 544,584 |
| 2023-12-20 | Gline Matthew CEO | Shares withheld for taxes 10b5-1 | −10,945 | $9.96 | $109K | 1,006,488 |
| 2023-12-20 | Kumar Rakhi Chief Accounting Officer | Shares withheld for taxes 10b5-1 | −1,364 | $9.96 | $14K | 192,282 |
| 2023-11-29 | Pulik Richard CFO | Other disposition 10b5-1 | −2,360 | $9.13 | $22K | 274,922 |
| 2023-11-22 | Venker Eric President & COO | Other disposition 10b5-1 | −16,549 | $8.68 | $144K | 560,587 |
| 2023-11-22 | Kumar Rakhi Chief Accounting Officer | Other disposition 10b5-1 | −1,415 | $8.68 | $12K | 193,646 |
| 2023-11-22 | Gline Matthew CEO | Other disposition 10b5-1 | −11,318 | $8.68 | $98K | 1,017,433 |
| 2023-10-30 | Pulik Richard CFO | Other disposition 10b5-1 | −2,360 | $8.39 | $20K | 277,352 |
| 2023-10-24 | Kumar Rakhi Chief Accounting Officer | Other disposition 10b5-1 | −1,563 | $8.99 | $14K | 195,061 |
| 2023-10-24 | Venker Eric President & COO | Other disposition 10b5-1 | −18,261 | $8.99 | $164K | 577,136 |
| 2023-10-24 | Gline Matthew CEO | Other disposition 10b5-1 | −12,489 | $8.99 | $112K | 1,028,751 |
| 2023-10-17 | MOMTAZEE JAMES C Director | Other disposition 10b5-1 | −687 | $10.30 | $7K | 74,769 |
| 2023-10-16 | Oren Ilan Director | Grant or award | +2,269 | 74,976 | ||
| 2023-10-16 | Epperly Melissa B, Director | Grant or award | +1,226 | 20,331 | ||
| 2023-10-16 | Fitzgerald Meghan Director | Grant or award | +1,269 | 11,358 |
Page 35 of 38 · 748 trades